San Francisco, California
London, United Kingdom
Understanding how cells interact with surfaces is key to a host of applications in biomedical science from regenerative medicine and drug delivery to biosensors. This multidisciplinary symposium will highlight both exciting advances in engineered biomaterials and in state of the art imaging approaches to enable exploration and engineering of the cell-material interface.
14:00 Welcome and opening remarks
Jim Smith, NIMR
14:10 Microengineered hydrogels for stem cell bioengineering and tissue regeneration
Ali Khademhosseini, Harvard
14:50 New Biomaterials-based approaches for regenerative medicine
Molly Stevens, Imperial College London
15:30 Structural biology looks at the cell
Peter Rosenthal, NIMR
16.40 Emerging fluorescence imaging technology to study the spatial
and temporal dynamics of molecules within living cells
Jennifer Lippincott-Schwartz, NIH
17:20 Molecular Bionics: Copying nature to control nature
Giuseppe Battaglia, UCL
18:10 Drinks reception
Registration is essential. To book a place please click on the link to register.
The event will take place in the Beveridge Hall at Senate House, Malet Street, London, WC1E 7HU.
Nearest underground stations are Goodge Street (Northern Line) and Russell Square (Piccadilly Line)
If you have any queries please email firstname.lastname@example.org
When & Where
The Francis Crick Institute
The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illness such as cancer, heart disease, stroke, infections and neurodegenerative diseases.
By bringing together scientists from many disciplines, the Crick will have the scale, vision and expertise to tackle the most challenging scientific questions underpinning health and disease.
The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London.